MetaADEDB 2.0 @ LMMD
Sulfanilamide
(FDDDEECHVMSUSB-UHFFFAOYSA-N)
Structure
SMILES
Nc1ccc(cc1)S(=O)(=O)N
Type(s)
Approved
ATC code(s)
D06BA05; G01AE10; J01EB06
Molecular Formula:
C6H8N2O2S
Molecular Weight:
172.205
Log P:
2.2785
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
94.56
CAS Number(s):
63-74-1
Synonym(s)
1.
Sulfanilamide
2.
4-Aminobenzenesulfonimidic acid
External Link(s)
PubChem Compound129828936
5333
BindingDB10857
ChEBI45373
CHEMBLCHEMBL21
DrugBankDB00259
DrugCentral2521
KEGGcpd:C07458
dr:D08543
Therapeutic Target DatabaseD0T8BA
ZINC2101
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 1US FAERS
2UrticariaFAERS: 1US FAERS
3AbasiaOFFSIDES
4Abdominal PainOFFSIDES
5AdenocarcinomaOFFSIDES
6AmphetaminesOFFSIDES
7Anal FissureOFFSIDES
8AngioplastyOFFSIDES
9AnuriaCanada Vigilance: 1Canada Vigilance
10ApathyOFFSIDES
11Aphthous StomatitisOFFSIDES
12Apparent deathOFFSIDES
13Apparent life threatening eventOFFSIDES
14Bacteria stool identifiedOFFSIDES
15BedriddenOFFSIDES
16Benign neoplasm of prostateOFFSIDES
17Blood GlucoseOFFSIDES
18Blood cholesterol abnormalOFFSIDES
19Blood glucose decreasedOFFSIDES
20Blood glucose fluctuationOFFSIDES
21Blood pressure fluctuationOFFSIDES
22Blood testosterone abnormalOFFSIDES
23Cardiac TamponadeOFFSIDES
24Cardiovascular insufficiencyOFFSIDES
25Catheter placementOFFSIDES
26Chemotherapeutic drug level increasedOFFSIDES
27Chest PainOFFSIDES
28ChokingOFFSIDES
29Circumstance or information capable of leading to medication errorOFFSIDES
30Clostridium colitisOFFSIDES
31Cold sweatOFFSIDES
32ColitisOFFSIDES
33Complications of transplant surgeryOFFSIDES
34Concomitant disease aggravatedOFFSIDES
35ConfabulationOFFSIDES
36Cytomegalovirus test positiveOFFSIDES
37Decreased LibidoOFFSIDES
38DiabetesOFFSIDES
39DizzinessOFFSIDES
40DrowsinessOFFSIDES
41Drug exposure during pregnancyOFFSIDES
42DysuriaOFFSIDES
43EczemaCanada Vigilance: 1Canada Vigilance
44Eosinophilic myocarditisOFFSIDES
45EpilepsyOFFSIDES
46EpistaxisOFFSIDES
47Eye painOFFSIDES
48Febrile NeutropeniaOFFSIDES
49Feeling abnormalOFFSIDES
50HemiplegiaOFFSIDES
51Hepatitis BOFFSIDES
52HepatitisOFFSIDES
53HypophagiaOFFSIDES
54Impaired self-careOFFSIDES
55Intestinal ObstructionOFFSIDES
56IntubationOFFSIDES
57Kidney FailureOFFSIDES
58Limb injuryOFFSIDES
59MonoplegiaOFFSIDES
60Neonatal pneumoniaOFFSIDES
61No adverse effectOFFSIDES
62NoduleOFFSIDES
63Obesity surgeryOFFSIDES
64Pericardial effusionOFFSIDES
65Poor peripheral circulationOFFSIDES
66Poor quality drug administeredOFFSIDES
67Rash erythematousCanada Vigilance: 1Canada Vigilance
68Respiratory FailureOFFSIDES
69Septic ShockOFFSIDES
70SinusitisOFFSIDES
71Skin neoplasm excisionOFFSIDES
72Thoracic cavity drainageOFFSIDES
73Throat cancerOFFSIDES
74Tooth LossOFFSIDES
75Vascular bypass graftOFFSIDES
76Venous occlusionOFFSIDES
77Ventricular hypokinesiaOFFSIDES
78Viral myocarditisOFFSIDES
79Visual disturbanceOFFSIDES
80Weight GainOFFSIDES
81Wound InfectionOFFSIDES
82effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.